Huang Z, Xie N, Illes P, Di Virgilio F, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C (2021) From purines to purinergic signalling: molecular functions and human diseases. Signal Transduct Target Ther 6:162

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:2398212818817494

Article  PubMed  PubMed Central  Google Scholar 

Sarikaya E (2019) Functions of purinergic receptors. In Receptors P1 and P2 as targets for drug therapy in humans, IntechOpen: 2019

da Silva Ferreira NC, Alves LA, Soares-Bezerra RJ (2019) Potential therapeutic applications of P2 receptor antagonists: from bench to clinical trials. Curr Drug Targets 20:919–937

Article  PubMed  Google Scholar 

Maynard JP, Sfanos KS (2022) P2 purinergic receptor dysregulation in urologic disease. Purinergic Signal 18:267–287

Article  PubMed  PubMed Central  CAS  Google Scholar 

Draganov D, Han Z, Rana A, Bennett N, Irvine DJ, Lee PP (2021) Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer. NPJ Breast Cancer 7:22

Article  PubMed  PubMed Central  CAS  Google Scholar 

Douguet L, dit Hreich SJ, Benzaquen J, Seguin L, Juhel T, Dezitter X, Duranton C, Ryffel B, Kanellopoulos J, Delarasse C (2021) A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy. Nat Comm 12:653

Article  CAS  Google Scholar 

Campos-Contreras ADR, Díaz-Muñoz M, Vázquez-Cuevas FG (2020) Purinergic signaling in the hallmarks of cancer. Cells 9:1612

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu X, Li Q, Song W, Peng X, Zhao R (2021) P2X7 receptor: a critical regulator and potential target for breast cancer. J Mol Med 99:349–358

Article  PubMed  CAS  Google Scholar 

Xia J, Yu X, Tang L, Li G, He T (2015) P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep 34:103–110

Article  PubMed  CAS  Google Scholar 

Maynard JP, Lu J, Vidal I, Hicks J, Mummert L, Ali T, Kempski R, Carter AM, Sosa RY, Peiffer LB (2022) P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer. J Pathol 256:149–163

Article  PubMed  CAS  Google Scholar 

Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R (2022) ATP-gated P2X7 receptor as a potential target for prostate cancer. Hum Cell 35:1346–1354

Article  PubMed  CAS  Google Scholar 

Li Q, Zhu X, Song W, Peng X, Zhao R (2020) The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. J Cancer Res Clin Oncol 146:2731–2741

Article  PubMed  CAS  Google Scholar 

Placet M, Arguin G, Molle CM, Babeu J-P, Jones C, Carrier JC, Robaye B, Geha S, Boudreau F, Gendron F-P (2018) The G protein-coupled P2Y6 receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis 1864:1539–1551

Hu L-P, Zhang X-X, Jiang S-H, Tao L-Y, Li Q, Zhu L-L, Yang M-W, Huo Y-M, Jiang Y-S, Tian G-A (2019) Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin Cancer Res 25:1318–1330

Article  PubMed  CAS  Google Scholar 

Maynard JP, Lee J-S, Sohn BH, Yu X, Lopez-Terrada D, Finegold MJ, Goss JA, Thevananther S (2015) P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget 6:41162

Article  PubMed  PubMed Central  Google Scholar 

Liu Z, Liu Y, Xu L, An H, Chang Y, Yang Y, Zhang W, Xu J (2015) P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma. Cancer Sci 106:1224–1231

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ledderose S, Rodler S, Eismann L, Ledderose G, Rudelius M, Junger WG, Ledderose C (2023) P2X1 and P2X7 receptor overexpression is a negative predictor of survival in muscle-invasive bladder cancer. Cancers 15:2321

Article  PubMed  PubMed Central  CAS  Google Scholar 

Idzko M, Ferrari D, Eltzschig HK (2014) Nucleotide signalling during inflammation. Nature 509:310–317

Article  PubMed  PubMed Central  CAS  Google Scholar 

White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27:211–217

Article  PubMed  CAS  Google Scholar 

Mühleder S, Fuchs C, Basílio J, Szwarc D, Pill K, Labuda K, Slezak P, Siehs C, Pröll J, Priglinger E (2020) Purinergic P2Y 2 receptors modulate endothelial sprouting. Cell Mol Life Sci 77:885–901

Article  PubMed  Google Scholar 

Rayah A, Kanellopoulos JM, Di Virgilio F (2012) P2 receptors and immunity. Microbes Infect 14:1254–1262

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cao Y, Chen E, Wang X, Song J, Zhang H, Chen X (2023) An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential. Cancer Cell Int 23:1–16

Article  Google Scholar 

Anderson NM, Simon MC (2020) The tumor microenvironment. Curr Biol 30:R921–R925

Article  PubMed  PubMed Central  CAS  Google Scholar 

Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601–618

Article  PubMed  Google Scholar 

de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374–403

Article  PubMed  Google Scholar 

Denk D, Greten FR (2022) Inflammation: the incubator of the tumor microenvironment. Trends Cancer 8:901

Article  PubMed  CAS  Google Scholar 

Canli Ö, Nicolas AM, Gupta J, Finkelmeier F, Goncharova O, Pesic M, Neumann T, Horst D, Löwer M, Sahin U (2017) Myeloid cell-derived reactive oxygen species induce epithelial mutagenesis. Cancer Cell 32(869–883):e865

Google Scholar 

Jacob F, Novo CP, Bachert C, Van Crombruggen K (2013) Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses. Purinergic Signal 9:285–306

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cekic C, Linden J (2016) Purinergic regulation of the immune system. Nat Rev Immunol 16:177–192

Article  PubMed  CAS  Google Scholar 

Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461:282–286

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hernandez C, Huebener P, Schwabe RF (2016) Damage-associated molecular patterns in cancer: a double-edged sword. Oncogene 35:5931–5941

Article  PubMed  PubMed Central  CAS  Google Scholar 

Murao A, Aziz M, Wang H, Brenner M, Wang P (2021) Release mechanisms of major DAMPs. Apoptosis 26:152–162